drugset / Trial / NCT07466381
Oxyhydrogen Nanobubble Infusion as a Complementary Therapy in Patients With Parkinsonism
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study was to determine the effect of oxyhydrogen nanobubble infusion on the degree of disease, cognitive function, and quality of life of patients with parkinsonism
Timeline
- Start
- 2024-11-01
- Primary completion
- 2025-11-30
- Completion
- 2026-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | oxyhydrogen nanobubble | Unknown | — | — |